Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
GNH India Pharmaceuticals Ltd. has withdrawn its Initial Public Offer (IPO) documents filed with the exchange on May 8, 2025.
GNH India Pharmaceuticals Ltd. IPO was a Book Build Issue
The equity shares were proposed to be listed on the NSE SME. Gretex Corporate Services Ltd. was the book running lead manager and Purva Sharegistry (India) Pvt.Ltd. was the registrar of the issue.
| IPO Date | [.] |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Issue Price Band | [.] to [.] per share |
| Lot Size | |
| Sale Type | Fresh Capital |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,01,57,140 shares |
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII Shares Offered | Not less than 15% of the Net Issue |
| Description | Date |
|---|---|
| Filed with SEBI/Exchange | Sat, Sep 21, 2024 |
| Offer document withdrawn | Thu, May 8, 2025 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in , GNH India Pharmaceuticals Limited engaged in the business of sourcing, distributing, and delivering a comprehensive range of pharmaceutical products, including orphan drugs, biologics, biosimilars, vaccines, and comparator drugs for clinical trials.
With a portfolio of over 135,000 product lines sourced from more than 250 suppliers and 110 distributors across key pharmaceutical markets worldwide, the company caters to the entire spectrum of pharmaceutical trade, including wholesale, tender supplies, and name patient access.
The company exports to over 180 countries and has established a strong presence in markets like the USA, Canada, Europe, and the Middle East.
Services:
As September 21, 2024, the company has 27 employees.
Competitive Strengths:
| Period Ended | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 36.36 | 41.19 | 23.63 |
| Total Income | 40.86 | 33.3 | 23.15 |
| Profit After Tax | 4.87 | 5.17 | 3.83 |
| Net Worth | 28.99 | 13.42 | 9.24 |
| Reserves and Surplus | 18.83 | 12.42 | 8.24 |
| Amount in ₹ Crore | |||
| KPI | Values |
|---|---|
| ROE | 22.99% |
| ROCE | 21.49% |
| RoNW | 16.81% |
| PAT Margin | 12.18% |
The Company Gnh India IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (in Millions) |
|---|---|---|
| 1 | Purchase of Plant & Machinery for Setting up of Cold Storage Facility | 44.18 |
| 2 | Design, Development & Maintenance of Mobile Application | 39.81 |
| 3 | Advertisement and Digital Marketing Activities | 6.6 |
| 4 | Working Capital Requirements | 213.7 |
| 5 | General Corporate Purposes |
GNH India Pharmaceuticals Ltd.
Unit No.14, 15, 16, 17, Ground Floor, Prabhadevi
Industrial Estate, Enterprises Industrial Premises
408, Veer Sawarkar Road, Prabhadevi,
Mumbai, Maharashtra, 400025
Phone: 022-62706900
Email: info@gnhindia.com
Website: http://www.gnhindia.com/
Purva Sharegistry (India) Pvt.Ltd.
Phone: +91-022-23018261/ 23016761
Email: newissue@purvashare.com
Website: https://www.purvashare.com/investor-service/ipo-query
GNH India Pharmaceuticals IPO is a SME IPO of 0 equity shares of the face value of ₹10 aggregating up to ₹[.] Crores. The issue is priced at . The minimum order quantity is .
The GNH India Pharmaceuticals IPO open and close dates are not available as of now.
Purva Sharegistry (India) Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Zerodha customers can apply online in GNH India Pharmaceuticals IPO using UPI as a payment gateway. Zerodha customers can apply in GNH India Pharmaceuticals IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in GNH India Pharmaceuticals IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The GNH India Pharmaceuticals IPO dates are not announced. Please check back again after some time.
GNH India Pharmaceuticals IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in GNH India Pharmaceuticals IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for GNH India Pharmaceuticals IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the GNH India Pharmaceuticals IPO allotment status.
The GNH India Pharmaceuticals IPO listing date is not yet announced. The tentative date of GNH India Pharmaceuticals IPO listing is [.].
Useful Articles
